Percutaneous Coronary Intervention in Women: In-Hospital Clinical Outcome. Experience from a Single Private Institution in Melbourne

Heart Lung and Circulation

Volumn 17, Issue SUPPL. 4, 2008, Pages

  Oqueli, Ernesto ^a   Baker, Leonie ^a   Carroll, Aaron ^a   Hiscock, Martin ^a   Dick, Ronald ^a  

^a EPWORTH HOSPITAL   (Australia)

Author keywords

Drug eluting stents and women; In hospital outcomes post PCI and gender; PCI and gender differences; PCI in women; Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; AGED; ANGIOGRAPHY; ARTICLE; AUSTRALIA; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL CARE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PRIVATE HOSPITAL; SEX DIFFERENCE; ST SEGMENT ELEVATION; STROKE;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; AUSTRALIA; FEMALE; HEART CATHETERIZATION; HOSPITAL MORTALITY; HOSPITALS, PRIVATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE;

EID: 56949083371     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2008.08.002     Document Type: Article

References (31)

1. Mikhail G.W. Coronary revascularisation in women. Heart 92 Suppl. III (2006) iii19-iii23
2. Lansky A.J., Hochman J.S., Ward P.A., Mintz G.S., Fabunmi R., Berger P.B., New G., Grines C.L., Pietras C.G., Kern M.J., Ferrell M., Leon M.B., Mehran R., White C., Mieres J.H., Moses J.W., Stone G.W., and Jacobs A.K. Percutaneous coronary intervention and adjunctive pharmacotherapy in women. A statement for healthcare professionals from the American Heart Association. Circulation 111 (2005) 940-953
3. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
4. Watanabe C.T., Maynard C., and Ritchie Jl. Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol 88 (2001) 848-852
5. Argulian E., PatelAD, Abramson J.L., Kulkarni A., Champney K., Palmer S., Weintraub W., Wenger N.K., and Vaccarino V. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 98 (2006) 48-53
6. Hurtado-Martinez J., Pinar-Bermudez E., Teruel-Carillo F., Gimeno-Blanes J.R., LacunzapRuiz J., Valdesuso R., Gracia-Alberola A., and Valdes-Chavarri M. In-hospital and long-term mortality in women with acute myocardial infarction treated by primary angioplasty. Rev Esp Cardiol 59 11 (2006) 1113-1122
7. Cheng C.-I., Kuo-Ho Yeh, Hsueh-Wen Chang, Teng-Hung Yu, Yen-Hsun Chen, Han-Tan Chai, and Hon-Kan Yip. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest 126 (2004) 47-53
8. Berger J.S., and Brown D.L. Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarction. Am J Cardiol 98 (2006) 1140-1143
9. Mehilli J., Ndrepepa G., Kastrati A., Neumann F.J., Berg Jt., Bruskina O., Dotzer F., Seyfarth M., Pache J., Kufner S., Dirschinger J., Berger P.B., and Schömig A. Sex and effect of abciximab in patients with acute coronary syndromes treated with percuataneous coronary interventions: Results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 Trial. Am Heart J 154 (2007) 158.e1-158.e7
10. Angeja B.G., Gibson C.M., Chin R., Frederick P.D., Every N.R., Ross A.M., Stone G.W., and Barron H.V. Participants in the National Registry of Myocardial Infarction 2-3 Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol 89 (2002) 1156-1161
11. Ayanian J.Z., and Epstein A.M. Differences in the use of procedures between men and women hospitalized for coronary disease. N Engl J Med 325 (1991) 221-225
12. Shaw L.J., Miller D.D., Romeis J.C., Kargl D., Younis L.T., and Chaitman B.R. Gender differences in the non-invasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 120 (1994) 559-566
13. Rathore S.S., Wang Y., Radford M.J., Ordin D.L., and Krumholz H.M. Sex differences in cardiac catheterization after acute myocardial infarction: the role of procedure appropriateness. Ann Intern Med 137 (2002) 487-493
14. Shulmann K.A., Berlin J.A., Harless W., Kerner J.F., Sistrunk S., Gersh B.J., Dube R., Taleghani C.K., Burke J.E., Williams S., Eisenberg J.M., and Escarce J.J. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 340 (1999) 618-626
15. Roeters van Lennep J.E., Zwinderman A.H., Roeters van Lennep H.W., Westerveld H.E., Plokker H.W., Voors A.A., Bruschke A.V., and van der Wall E.E. Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome. Eur Heart J 21 (2000) 911-918
16. Bell M.R., Berger P.B., Holmes Jr. D.R., Mullany C.J., Bailey K.R., and Gersh B.J. Referral for coronary artery revascularization procedures after diagnostic coronary angiography; evidence for gender bias?. J Am Coll Cardiol 25 (1995) 1650-1655
17. Ghali W.A., Faris P.D., Galbraith P.D., Norris C.M., Curtis M.J., Saunders L.D., Dzavik V., Mitchell L.B., and Knudtson M.L. Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators Sex differences in access to coronary revascularization after cardiac catheterization: importance of detailed clinical data. Ann Inter Med 136 (2002) 723-732
18. Jacobs A.K., Johnston J.M., Haviland A., Brooks M.M., Kelsey S.F., Holmes D.R., Faxon D.P., Williams D.O., and Detre K.M. Improved outcomes for women undergoing contemporary percutaneous coronary intervention, A Report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC 39 (2002) 1608-1614
19. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330 (1994) 956-961
20. Lincoff A.M., Tcheng J.E., Califf R.M., Kereiakes D.J., Kelly T.A., Timmis G.C., Kleiman N.S., Booth J.E., Balog C., Cabot C.F., Anderson K.M., Weisman H.F., and Topol E.J. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with Abciximab; one year outcome in the EPILOG trial Evaluation in PTCA to Improve Long-term Outcome with Abciximab GP IIb/IIIa blockade. Circulation 99 (1999) 1951-1958
21. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 336 (1997) 1689-1696
22. Topol T.J. The EPISTENT investigators randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of platelet IIb/IIIa Inhibitor for Stenting. Lancet 352 (1998) 87-92
23. Cho L., Topol E.J., Balog C., Foody J.M., Booth J.E., Cabot C., Kleinman N.S., Tcheng J.E., Califf R., and Lincoff A.M. Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: pooledanalysis from EPIC, EPILOG, and EPISTENT trials. Evaluation of c7E3 for the Prevention of Ischaemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa inhibitor for stent. J Am Coll Cardiol 36 (2000) 381-386
24. De Luca G., Suryapranata H., Ottervanger J.P., and Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction Every minute of delay counts. Circulation 109 (2004) 1223-1225
25. Hasdai D., Califf R.M., Thompson T.D., Hochman J.S., Ohman E.M., Pfisterer M., Bates E.R., Vahanian A., Armstrong P.W., Criger D.A., Topol E.J., and Holmes Jr. D.R. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 35 (2000) 136-143
26. Marrugat J., Sala J., Masia R., Pavesi M., Sanz G., Valle V., Molina L., and Serés L. Elosua R for the RESCATE investigators mortality differences between men and women following first myocardial infarction. JAMA 280 (1998) 1405-1409
27. Kelsey S.F., James M., Holubkov R., Cowley M.J., and Detre K.M. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation 87 (1993) 720-727
28. Mandak J.S., Blankenship J.C., Gardner L.H., Berkowitz S.D., Aguirre F.V., Sigmon K.N., Timmis G.C., Gilehrist I.C., McIvor M., Resar J., Weiner B.H., George B.S., Talley J.D., Lincoff A.M., Tcheng J.E., Califf R.M., and Topol E.J. Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide integrilin to minimize platelet aggregation and coronary thrombosis. J Am Coll Cardiol 31 (1998) 1518-1524
29. Lincoff A.M., Tcheng J.E., Califf R.M., BassT, Popma J.J., Teirstein P.S., Kleinman N.S., Hattel L.J., Anderson H.V., Ferguson J.J., Cabot C.F., Anderson K.M., Berdan L.G., Musco M.H., Weisman H.F., and Topol E.J. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization PROLOG Investigators. Am J Cardiol 79 (1997) 286-291
30. Lansky A.J., Pietras C., Costa R.A., Tsuchiya Y., Brodie B.R., Cox D.A., Aymong E.D., Stuckey T.D., Garcia E., Tcheng J.E., Mehran R., Negoita M., Fahy M., Cristea E., Turco M., Leon M.B., Grines C.L., and Stone G.W. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the controlled abciximab and device investigation to lower late angioplasty complications CADILLAC Trial. Circulation 111 (2005) 1611-1618
31. Peterson E.D., Lansky A.J., Kramer J., Anstrom K., and Lanzilotta M.J. National Cardiovascular Network Clinical Investigators Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 88 (2001) 359-364